[1]任虹,杨丽霞,吴丽丽,等.止消通脉宁干预TGF—β1诱导HK—2细胞增殖的研究[J].西部中医药,2012,25(08):10-13.
 REN Hong,YANG Li-xia,WU Li-li,et al.Intervention of ZhiXiao TongMaiNing on Proliferation of Human Renal Tubular Epithelial Cell HK-2 Induced by TGF-β1[J].Western Journal of Traditional Chinese Medicine,2012,25(08):10-13.
点击复制

止消通脉宁干预TGF—β1诱导HK—2细胞增殖的研究
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
25
期数:
2012年08期
页码:
10-13
栏目:
出版日期:
2012-08-15

文章信息/Info

Title:
Intervention of ZhiXiao TongMaiNing on Proliferation of Human Renal Tubular Epithelial Cell HK-2 Induced by TGF-β1
文章编号:
1004-6852(2012)08-0010-04
作者:
任虹1杨丽霞2吴丽丽2刘铜华3△Margetts Peter Joseph4
1 兰州市西固区人民医院,甘肃 兰州 730060; 2 甘肃省中医药研究院; 3 北京中医药大学; 4 McMaster University, Hamilton Ontario,Canada T3309
Author(s):
REN Hong1, YANG Li-xia2, WU Li-li2, LIU Tong-hua3△, Margetts Peter Joseph4
1 People′s Hospital in Xigu District of Lanzhou City, Lanzhou 730060, China; 2 GanSu Province Academy of Chinese Medicine; 3 Beijing University of Chinese Medicine; 4 McMaster University, Hamilton T3309, Canada
关键词:
TGF-β1HK-2细胞止消通脉宁增殖
Keywords:
TGF-β1 HK-2 cell ZhiXiao TongMaiNing proliferation
分类号:
R285.5
文献标志码:
A
摘要:
目的:通过观察止消通脉宁含药血清对转化生长因子-β1(TGF-β1)诱导人肾小管上皮细胞(HK-2)增殖的影响,探讨治疗糖尿病肾病有效中药复方止消通脉宁在防治肾间质纤维化方面的作用。方法:将HK-2细胞用含10%胎牛血清的 DMEM/F12(1∶1)培养基培养;实验分为6组:空白对照组、单纯TGF-β1诱导组(TGF-β110 ng/mL)、空白血清对照组(TGF-β110 ng/mL+10%空白血清)、干预1组(TGF-β110 ng/mL +10%低剂量止消通脉宁含药血清)、干预 2 组(TGF-β110 ng/mL+10%中剂量止消通脉宁含药血清)、干预3组(TGF-β110 ng/mL +10%高剂量止消通脉宁含药血清)。倒置显微镜下观察各组细胞形态,MTT法检测细胞增殖。结果:TGF-β110 ng/ mL 能显著诱导人肾小管上皮细胞增殖,与空白对照组相比有显著性差异(P<0.05),且其作用随处理时间的延长而增强,但和止消通脉宁含药血清共同作用后,其促细胞增殖作用受到一定抑制(P<0.05)。结论:止消通脉宁能抑制HK-2细胞增殖,在一定程度上具有防治肾间质纤维化的作用。
Abstract:
Objective: To explore the mechanism of ZhiXiao TongMaiNing in the prevention and treatment of renal interstitial fibrosis by observing the influence of ZhiXiao TongMaiNing on proliferation of human renal tubular epithelial cells HK-2 induced by transforming growth factor-β1(TGF-β1). Method: HK-2 cells were cultured with DMEM/F12 (1:1) containing 10% fetal bovine serum and divided into control group, TGF-β1 group(TGF-β110 ng/mL), control group of animal serum (TGF-β110 ng/mL +10% animal serum), first intervention group (TGF-β110 ng/mL + 10 % low dose of ZhiXiao TongMaiNing), second intervention group(TGF-β110 ng/mL + 10% middle dose of ZhiXiao TongMaiNing) and third intervention group(TGF-β110 ng/mL + 10 % high dose of ZhiXiao TongMaiNing). HK-2 cell morphology and cell proliferation were observed respectively through the microscope and MTT assay. Result: 10 ng/mL TGF-β1could induce remarkably proliferation of human renal tubular epithelial cells HK-2, comparison indicated notable difference with blank control group(P<0.05), it can enhance with the growth of time, but cell proliferation was inhibited to a certion extent after combination with ZhiXiao TongMaiNing(P<0.05). Conclusion: ZhiXiao TongMaiNing can inhibit the proliferation of HK-2 and prevent renal fibrosis to some extent.

相似文献/References:

[1]汪雪晴.解毒消银汤配合青黛散外敷治疗寻常型银屑病疗效观察[J].西部中医药,2014,27(03):100.
 WANG Xueqing.Curative Observation on Treating Psoriasis Vulgaris by JieDu XiaoYin Tang and QingDai Powder for External Use[J].Western Journal of Traditional Chinese Medicine,2014,27(08):100.
[2]班志勇,韦桂莲,黄谢梅.银杏达莫注射液抗慢性胰腺炎纤维化的作用[J].西部中医药,2015,28(02):105.
[3]吉利,张艳.益气通脉饮对慢性心力衰竭大鼠心功能及血清TNF-α、IL-6、TGF-β1水平的影响[J].西部中医药,2015,28(05):25.
[4]舒畅,杨丽霞,程涛,等.基于 Smads 信号通路探讨止消通脉宁干预 TGF-β1诱导 HK-2 细胞转分化的研究*[J].西部中医药,2013,26(06):10.
 SHU Chang,YANG Lixia,CHENG Tao,et al.Research on Intervention of ZhiXiao TongMaiNing to Trans-differentiation of Human Renal Tubular Epithelial HK-2 Cell Induced by TGF-β1 Based on Smads Signaling Pathway[J].Western Journal of Traditional Chinese Medicine,2013,26(08):10.
[5]杨频,杨丽霞,刘铜华△,等.止消通脉宁对TGF-β1诱导的HK-2细胞Smad 2、3、7 mRNA表达的影响[J].西部中医药,2013,26(09):16.
 YANG Pin,YANG Lixia,LIU Tonghua,et al.The Effects of ZhiXiao TongMaiNing on Smad 2, Smad 3 and Smad 7 mRNA Expressions of Human Renal Tubular Epithelial Cells HK-2 Induced by TGF-β1[J].Western Journal of Traditional Chinese Medicine,2013,26(08):16.

备注/Memo

备注/Memo:
收稿日期:2012-04-20 *基金项目:科技部国际科技合作项目(编号2009DFA31520) 作者简介:任虹(1967—),女,副主任医师。研究方向:肾脏疾病的治疗。 △通讯作者:刘铜华(1963—),男,博士研究生导师,博士学位,教授。研究方向:糖尿病及其并发症的中医药防治。
更新日期/Last Update: 2012-08-15